The innovator’s mindset is shifting from solving the problems right in front of us to solving problems once considered impossible to fix. The lines between curable and incurable diseases are blurring in surgery because medical devices are scaling up precision and scaling down the size of anatomy that surgeons can operate on.
Contract developer Minnetronix Medical recently developed and commercialized its own product: MindsEye, which it says is the first minimally invasive deep brain access port. The port addresses an unmet need in the neurology market — certain forms of stroke and cancer cause lesions that are deep in the brain, and removing them can be a very invasive and dangerous process.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The medical device innovation journey is long and difficult and requires a culture of commitment and foresight that goes beyond the immediate team, extending to all disciplines within the business.